Top Markets
#1 CoW Protocol CoW Protocol +84.93%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +38.25%
#4 Walrus Walrus +36.32%
#5 Humanity Humanity +16.84%
#6 Velvet Velvet +16.00%
#7 Cysic Cysic +15.83%
#8 The Black Bull The Black Bull +14.62%
#9 Tutorial Tutorial +14.59%
#10 Plume Plume +14.14%
Coin of the day
CoW Protocol CoW Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Awakn Life Sciences Corp. Awakn Life Sciences Corp.

Awakn Life Sciences Corp.

AWKN
Rank in Stocks #37130
Awakn Life Sciences Corp., a biotechnology firm headquartered in Toronto,... Awakn Life Sciences Corp., a biotechnology firm headquartered in Toronto, Canada, specializes in the discovery, development, and provision of psychedelic therapies. Its mission is to address addiction and other mental health challenges throughout the United Kingdom and across Europe.
Share Price
$0.07726075
Last synced: 2024-12-13
Market Cap
$1.99M
Change (1 day)
5.27%
Change (1 year)
0.00%
Country
CA
Trade Awakn Life Sciences Corp. (AWKN)

Category

Healthcare
Revenue for Awakn Life Sciences Corp. (AWKN)
Revenue in Aug 2026 TTM: 0
According to Awakn Life Sciences Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Awakn Life Sciences Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE